123 related articles for article (PubMed ID: 33155206)
1. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.
Aydin MA; Gul G; Kiziltan R; Algul S; Kemik O
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10512-10517. PubMed ID: 33155206
[TBL] [Abstract][Full Text] [Related]
2. Nucleosome assembly protein 1-like 1 (NAP1L1) in gastric cancer patients: a potential biomarker with diagnostic and prognostic utility.
Gul G; Aydin MA; Algul S; Kiziltan R; Kemik O
Biomarkers; 2024 Feb; 29(1):30-35. PubMed ID: 38258494
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
[TBL] [Abstract][Full Text] [Related]
4. NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
Liang X; Tang Z; Zhang Y; Sun Y; Wang J
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1234-1243. PubMed ID: 36148951
[TBL] [Abstract][Full Text] [Related]
5. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
6. NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of
Queiroz CJS; Song F; Reed KR; Al-Khafaji N; Clarke AR; Vimalachandran D; Miyajima F; Pritchard DM; Jenkins JR
Front Oncol; 2020; 10():1565. PubMed ID: 32850460
[TBL] [Abstract][Full Text] [Related]
7. NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma.
Le Y; Kan A; Li QJ; He MK; Chen HL; Shi M
Cancer Cell Int; 2019; 19():228. PubMed ID: 31516385
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of nucleosome assembly protein 1-like 1 induces mesoderm formation and cardiomyogenesis via notch signaling in murine-induced pluripotent stem cells.
Gong H; Yan Y; Fang B; Xue Y; Yin P; Li L; Zhang G; Sun X; Chen Z; Ma H; Yang C; Ding Y; Yong Y; Zhu Y; Yang H; Komuro I; Ge J; Zou Y
Stem Cells; 2014 Jul; 32(7):1759-73. PubMed ID: 24648372
[TBL] [Abstract][Full Text] [Related]
9. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
11. Nucleosome Assembly Protein 1-Like 1 (Nap1l1) Regulates the Proliferation of Murine Induced Pluripotent Stem Cells.
Yan Y; Yin P; Gong H; Xue Y; Zhang G; Fang B; Chen Z; Li Y; Yang C; Huang Z; Yang X; Ge J; Zou Y
Cell Physiol Biochem; 2016; 38(1):340-50. PubMed ID: 26824453
[TBL] [Abstract][Full Text] [Related]
12. Decreased preoperative serum fibulin-3 levels in colon cancer patients.
Simsek O; Kocael A; Kemik A; Vatankulu B; Kocael P; Halac M; Ulualp K; Sonmezoglu K
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4076-80. PubMed ID: 26592829
[TBL] [Abstract][Full Text] [Related]
13. [Association of serum inflammatory cytokines and Resolvin D1 concentration with pathological stage of colon cancer].
Zhuang Q; Meng Q; Xi Q; Wu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1285-1290. PubMed ID: 30506541
[TBL] [Abstract][Full Text] [Related]
14. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
15. Serum annexin A2 levels in patients with colon cancer in comparison to healthy controls and in relation to tumor pathology.
Gurluler E; Guner OS; Tumay LV; Turkel Kucukmetin N; Hizli B; Zorluoglu A
Med Sci Monit; 2014 Oct; 20():1801-7. PubMed ID: 25287627
[TBL] [Abstract][Full Text] [Related]
16. A novel screening test for colon cancer: Talin-1.
Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients.
Giaginis C; Margeli A; Kouraklis G; Zira A; Tsourouflis G; Theocharis S
Int J Biol Markers; 2009; 24(2):70-6. PubMed ID: 19634109
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of TRIM72 Are Lower among Patients with Colon Cancer: Identification of a Potential Diagnostic Marker.
Chen Z; Yin X; Li K; Chen S; Li H; Li Y; Zhang Q; Wang H; Qiu Y
Tohoku J Exp Med; 2018 May; 245(1):61-68. PubMed ID: 29806630
[TBL] [Abstract][Full Text] [Related]
19. Discovery and validation of new potential biomarkers for early detection of colon cancer.
Solé X; Crous-Bou M; Cordero D; Olivares D; Guinó E; Sanz-Pamplona R; Rodriguez-Moranta F; Sanjuan X; de Oca J; Salazar R; Moreno V
PLoS One; 2014; 9(9):e106748. PubMed ID: 25215506
[TBL] [Abstract][Full Text] [Related]
20. Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fate.
Tanaka T; Hozumi Y; Martelli AM; Iino M; Goto K
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118560. PubMed ID: 31634504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
